IMFINZI (Durvalumab)-50mg

IMFINZI (Durvalumab) is a form of immunotherapy and blocks the activity of programmed death-ligand 1 (PDL-1), a molecule found on T cells that suppress immune activity. By blocking PDL-1, T-cells function better and the immune response is stimulated to find and kill cancer cells.

Durvalumab is used to treat;

•  a type of cancer in the bladder and urothelial cancers
• unresectable Stage 3 non-small cell lung cancer (NSCLC)